News

May 13, 2026

SyVento BioTech is pleased to announce the planned collaboration with NanoSanguis S.A. on the implementation of the project “𝗡𝗮𝗻𝗢𝗫 𝟰 𝗞𝗶𝗱𝗻𝗲𝘆 – 𝗮 𝗻𝗲𝘅𝘁-𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝗼𝗻 𝗸𝗶𝗱𝗻𝗲𝘆 𝗽𝗲𝗿𝗳𝘂𝘀𝗶𝗼𝗻 𝗳𝗹𝘂𝗶𝗱 𝗯𝗮𝘀𝗲𝗱 𝗼𝗻 𝗮 𝘀𝘆𝗻𝘁𝗵𝗲𝘁𝗶𝗰 𝗼𝘅𝘆𝗴𝗲𝗻 𝗰𝗮𝗿𝗿𝗶𝗲𝗿.” Under the anticipated agreement, SyVento will provide comprehensive technological and analytical support for the development and manufacturing process of a Class III […]

May 4, 2026

We are proud to announce that on 28 April 2026, SyVento BioTech officially received the Certificate of GMP Compliance of a Manufacturer, marking one of the most significant milestones in the company’s history. The certificate was granted following an inspection conducted under the national inspection programme, in connection with manufacturing authorisation no. 285/0662/25, and carried […]

April 27, 2026

SyVento BioTech is proud to be part of UK BioTech Day, a key meeting point for companies shaping the future of drug development, advanced therapies, and biotech commercialization. Our participation reflects SyVento BioTech’s focus on supporting biotech and pharmaceutical partners through expert regulatory, clinical, and commercial advisory services, from early development to market readiness. UK […]

April 20, 2026

This week, we are heading to Warsaw. On April 22–23, the next edition of CE BioForum will bring together key leaders from the life sciences and biotechnology sectors across Central and Eastern Europe. CE BioForum is a unique platform for meaningful conversations, strategic partnerships, and insights into the latest trends shaping the biotech ecosystem. It […]

April 11, 2026

In exactly one month, SyVento BioTech will be participating in TIDES USA: Oligonucleotide & Peptide Therapeutics in Boston. This is North America’s leading conference dedicated to advancing oligonucleotide and peptide-based medicines. We will be represented on site by Sujit Jain, Commercial Advisor, who will be available to discuss collaboration opportunities and our manufacturing capabilities. Our […]

April 9, 2026

We are pleased to announce that SyVento BioTech will be exhibiting at CDMO Live 2026, one of the leading industry events dedicated to contract development and manufacturing for the pharmaceutical and biotechnology sectors. CDMO Live brings together innovators, biotech companies, and service providers to address current challenges, emerging trends, and future directions in outsourced development […]

March 30, 2026

BIO KOREA 2026 is fast approaching, taking place in Seoul next month and once again bringing together leading global stakeholders in biotechnology, pharmaceuticals, medical technology, and research. As one of the most established life‑science events in Asia, it provides a dynamic platform for partnership building, scientific exchange, and showcasing innovations that drive the future of […]

March 6, 2026

SyVento BioTech is pleased to announce our participation in the upcoming World Vaccine Congress USA, taking place from 31 March to 2 April 2026 in Washington, D.C. This global forum brings together leading experts advancing the future of vaccine innovation, development and manufacturing. At SyVento BioTech, we support next generation vaccine and therapeutic programs with […]

March 4, 2026

With only one month left until the 5th LNP Formulation and Process Development Summit begins in Boston, SyVento BioTech is preparing to join this leading global forum focused on advancing lipid nanoparticle science. Taking place from 6 April to 8 April 2026, the summit will bring together experts driving innovation in LNP formulation, analytical development […]